NAD-ME anticorps
Aperçu rapide pour NAD-ME anticorps (ABIN7003513)
Antigène
Voir toutes NAD-ME AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Attributs du produit
- Polyclonal Antibody
-
Purification
- Antigen affinity purification
-
Immunogène
- Synthetic peptide of human ME2
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:500-1:2000, ELISA 1:5000-1:10000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.78 mg/mL
-
Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- NAD-ME (NAD Dependent Malate Dehydrogenase (NAD-ME))
-
Autre désignation
- ME2
-
Sujet
- This gene encodes a mitochondrial NAD-dependent malic enzyme, a homotetrameric protein, that catalyzes the oxidative decarboxylation of malate to pyruvate. It had previously been weakly linked to a syndrome known as Friedreich ataxia that has since been shown to be the result of mutation in a completely different gene. Certain single-nucleotide polymorphism haplotypes of this gene have been shown to increase the risk for idiopathic generalized epilepsy. Alternatively spliced transcript variants encoding different isoforms found for this gene.
-
Poids moléculaire
-
Observed_MW: Refer to figures
Calculated_MW: 65 kDa
-
UniProt
- P23368
-
Pathways
- Production of Molecular Mediator of Immune Response
Antigène
-